BRÈVE publiée le 22/05/2026 à 14:01, il y a 5 mois 13 jours Déclaration de Apex Fundrock Limited (formulaire 8.3) concernant Advanced Medical Sol Group PLC Gestion D'actifs Formulaire 8.3 Informations Sur Les Valeurs Mobilières Groupe De Solutions Médicales Avancées Poste À Pourvoir
BRÈVE publiée le 22/05/2026 à 14:01, il y a 5 mois 13 jours Apex Fundrock Limited's Form 8.3 Disclosure on Advanced Medical Sol Group PLC Asset Management Form 8.3 Securities Disclosure Opening Position Advanced Medical Sol Group
COMMUNIQUÉ DE PRESSE publié le 22/05/2026 à 13:56, il y a 5 mois 13 jours Form 8.3 - Advanced Medical Sol Group PLC - Opening Position Disclosure Chelverton Asset Management discloses a 1.36% interest in Advanced Medical Sol Group PLC. No other party disclosures made Interests Chelverton Asset Management Disclosures 1.36% Advanced Medical Sol Group PLC
BRÈVE publiée le 20/05/2026 à 15:37, il y a 5 mois 15 jours Disclosure of Investment Positions by Chelverton Asset Management in Checkit PLC Form 8.3 Takeover Code Securities Disclosure Chelverton Asset Management Checkit PLC
BRÈVE publiée le 20/05/2026 à 15:37, il y a 5 mois 15 jours Divulgation des positions d'investissement de Chelverton Asset Management dans Checkit PLC Code De Prise De Contrôle Formulaire 8.3 Information Sur Les Valeurs Mobilières Checkit PLC Gestion D'actifs De Chelsea
COMMUNIQUÉ DE PRESSE publié le 20/05/2026 à 15:32, il y a 5 mois 15 jours Form 8.3 - Checkit PLC Chelverton Asset Management discloses a 2.71% interest in Checkit PLC's Ordinary shares. No other parties involved in the offer Ordinary Shares Open Position Disclosure Chelverton Asset Management Checkit PLC 2.71%
BRÈVE publiée le 15/05/2026 à 15:19, il y a 5 mois 20 jours Disclosure Update on Gamma Communications PLC by Chelverton Asset Management Form 8.3 Securities Disclosure Share Sale Chelverton Asset Management Gamma Communications PLC
BRÈVE publiée le 15/05/2026 à 15:19, il y a 5 mois 20 jours Mise à jour des informations sur Gamma Communications PLC par Chelverton Asset Management Formulaire 8.3 Vente D'actions Information Sur Les Valeurs Mobilières Gestion D'actifs De Chelsea Gamma Communications PLC
COMMUNIQUÉ DE PRESSE publié le 15/05/2026 à 15:14, il y a 5 mois 20 jours Form 8.3 - Gamma Communications PLC Chelverton Asset Management discloses a 0.99% interest in Gamma Communications PLC. The dealing was undertaken on 14th May 2026 Dealing Disclosure Chelverton Asset Management Gamma Communications PLC 0.99% 14th May 2026
BRÈVE publiée le 15/05/2026 à 14:54, il y a 5 mois 20 jours Chelverton Asset Management Discloses Stake in Advanced Medical Solutions Form 8.3 Takeover Code Shareholding Disclosure Chelverton Asset Management Advanced Medical Solutions
Publié le 04/11/2026 à 18:00, il y a 10 heures 9 minutes The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 10 heures 9 minutes L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 10 heures 25 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 4 heures 59 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 5 heures 9 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 5 heures 54 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 6 heures 4 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 03:55, il y a 14 minutes AlphaESS Named a BloombergNEF Tier 1 Energy Storage Manufacturer for the Fifth Consecutive Quarter in Q4 2026
Publié le 05/11/2026 à 03:10, il y a 59 minutes SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Publié le 05/11/2026 à 00:02, il y a 4 heures 7 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 8 heures 28 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 8 heures 44 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
